JP2018532809A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532809A5
JP2018532809A5 JP2018543272A JP2018543272A JP2018532809A5 JP 2018532809 A5 JP2018532809 A5 JP 2018532809A5 JP 2018543272 A JP2018543272 A JP 2018543272A JP 2018543272 A JP2018543272 A JP 2018543272A JP 2018532809 A5 JP2018532809 A5 JP 2018532809A5
Authority
JP
Japan
Prior art keywords
hco
alkyl
formulation
polyoxyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018543272A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018532809A (ja
JP7793283B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/060391 external-priority patent/WO2017083167A1/en
Publication of JP2018532809A publication Critical patent/JP2018532809A/ja
Publication of JP2018532809A5 publication Critical patent/JP2018532809A5/ja
Priority to JP2022177207A priority Critical patent/JP7669326B2/ja
Application granted granted Critical
Publication of JP7793283B2 publication Critical patent/JP7793283B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018543272A 2015-11-10 2016-11-03 局所製剤およびその使用 Active JP7793283B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022177207A JP7669326B2 (ja) 2015-11-10 2022-11-04 局所製剤およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562253569P 2015-11-10 2015-11-10
US62/253,569 2015-11-10
PCT/US2016/060391 WO2017083167A1 (en) 2015-11-10 2016-11-03 Topical formulations and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022177207A Division JP7669326B2 (ja) 2015-11-10 2022-11-04 局所製剤およびその使用

Publications (3)

Publication Number Publication Date
JP2018532809A JP2018532809A (ja) 2018-11-08
JP2018532809A5 true JP2018532809A5 (enExample) 2019-12-12
JP7793283B2 JP7793283B2 (ja) 2026-01-05

Family

ID=58695926

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018543272A Active JP7793283B2 (ja) 2015-11-10 2016-11-03 局所製剤およびその使用
JP2022177207A Active JP7669326B2 (ja) 2015-11-10 2022-11-04 局所製剤およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022177207A Active JP7669326B2 (ja) 2015-11-10 2022-11-04 局所製剤およびその使用

Country Status (10)

Country Link
US (3) US20190231885A1 (enExample)
EP (2) EP3373976B1 (enExample)
JP (2) JP7793283B2 (enExample)
AU (1) AU2016351588A1 (enExample)
DK (1) DK3373976T3 (enExample)
ES (1) ES2974821T3 (enExample)
FI (1) FI3373976T3 (enExample)
PL (1) PL3373976T3 (enExample)
PT (1) PT3373976T (enExample)
WO (1) WO2017083167A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2887923T3 (pl) 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
DK3373976T3 (da) 2015-11-10 2024-04-02 Sun Pharmaceutical Ind Ltd Topiske formuleringer og anvendelser deraf
NZ785158A (en) * 2016-02-29 2025-03-28 Sun Pharmaceutical Ind Ltd Topical cyclosporine-containing formulations and uses thereof
US20240342086A1 (en) * 2021-08-20 2024-10-17 Sun Pharmaceutical Industries Limited Stable cyclosporine ophthalmic formulation and manufacturing process thereof

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
NZ247516A (en) 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
MX9701946A (es) 1997-03-14 1998-04-30 Arturo Jimenez Bayardo Solucion oftalmica transportadora.
US7678836B2 (en) 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
IL151299A0 (en) 2000-02-16 2003-04-10 Brigham & Womens Hospital Aspirin-triggered lipid mediators
US20030176356A1 (en) 2001-04-24 2003-09-18 University Of North Texas Health Science Center Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma
EP1435910B9 (en) 2001-10-19 2010-02-03 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
AU2002365167A1 (en) 2001-12-18 2003-07-09 The Brigham And Women's Hospital Inhibition or prevention of infection by bacteria with epa, dha or analogs
US6949664B2 (en) 2002-04-01 2005-09-27 University Of Southern California Trihydroxy polyunsaturated eicosanoids
US7582785B2 (en) 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
DK2216318T3 (en) 2002-08-12 2018-12-10 Brigham & Womens Hospital Resolvins: Bio templates for therapeutic interventions
US20040213782A1 (en) 2003-02-03 2004-10-28 Pharmacia Corporation Compositions of an aquaporin modulating agent and an aqueous humor modulating agent for the treatment of elevated intraocular pressure
JP2004238346A (ja) 2003-02-07 2004-08-26 Shiono Chemical Co Ltd トラニラストの安定な水溶液製剤
WO2004078143A2 (en) 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
AU2003228126A1 (en) 2003-05-02 2004-11-23 Arturo Jimenez Bayardo Method of preparing an aqueous solution of cyclosporin-a and resulting aqueous solution
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
EP1755537A4 (en) 2004-04-14 2009-12-09 Univ Boston METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
EP1655021B1 (en) 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
CA2588166A1 (en) 2004-11-19 2006-05-26 Martek Biosciences Corporation Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
WO2006132342A1 (ja) 2005-06-09 2006-12-14 Santen Pharmaceutical Co., Ltd. ロフルミラスト点眼液
CN102772358A (zh) 2005-06-16 2012-11-14 美瑞德生物工程公司 药物组合物及其用途
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
WO2007011880A2 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
EP1983977A4 (en) 2006-01-31 2011-11-30 Martek Biosciences Corp OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF
US10137083B2 (en) 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
US20090074874A1 (en) 2006-04-24 2009-03-19 Yuko Amano Process for Producing Polymer Micelles Encapsulating Low Molecular Weight Drugs
JPWO2007136134A1 (ja) 2006-05-23 2009-10-01 ナノキャリア株式会社 疎水性薬物内包ポリマーミセルの製造方法
KR101363498B1 (ko) 2006-07-18 2014-02-14 나노캬리아 가부시키가이샤 생리활성 폴리펩티드 또는 단백질 내포 고분자 폴리머 미셀및 그 제조방법
EP2120920A4 (en) 2007-02-20 2011-06-15 Martek Biosciences Corp OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
US20100310462A1 (en) 2007-04-18 2010-12-09 Biochromix Ab Binding of pathological forms of proteins using conjugated polyelectrolytes
US8512687B2 (en) 2007-07-09 2013-08-20 Novagali Pharma Sa Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
JP5327809B2 (ja) 2007-08-29 2013-10-30 わかもと製薬株式会社 ラタノプロスト含有水性医薬組成物
MX2007011165A (es) 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
JP5668476B2 (ja) 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
CN101990437A (zh) 2008-01-04 2011-03-23 阿尔康药品有限公司 稳定的环孢菌素水性组合物
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
BRPI0912302A2 (pt) 2008-05-28 2015-10-20 Alcon Res Ltd emulsões autopreservados
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
CA2763819A1 (en) 2009-06-02 2010-12-09 Nian WU Pure peg-lipid conjugates
EP2440185B1 (en) 2009-06-09 2015-04-08 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
CA2773597A1 (en) 2009-09-17 2011-03-24 Senju Pharmaceutical Co., Ltd. Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US9011861B2 (en) 2010-02-25 2015-04-21 Schepens Eye Research Institute Therapeutic compositions for the treatment of dry eye disease
BR112012028437A2 (pt) 2010-05-07 2016-07-19 Sun Pharma Advanced Res Co Ltd solução oftálmica, e, método para tratar glaucoma ou hipertensão ocular
US20130065888A1 (en) 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
US9278132B2 (en) 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
KR101211902B1 (ko) 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
BR112014028069A2 (pt) 2012-05-11 2017-08-08 Cipla Ltd composição farmacêutica oftálmica, processo para a preparação de uma composição farmacêutica oftálmica, uso de uma composição farmacêutica oftálmica, e, método para a prevenção ou tratamento de uma infecção fúngica
PL2887923T3 (pl) 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
US10946076B2 (en) 2013-02-13 2021-03-16 The Research Foundation For The State University Of New York Glaucoma treatment
WO2015179527A1 (en) 2014-05-23 2015-11-26 Ocular Technologies Sarl Topical formulations and uses thereof
US20150352176A1 (en) 2014-06-06 2015-12-10 Newport Research, Inc. Oil-free and fat-free aqueous suspensions of cyclosporin
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US20180133217A1 (en) 2015-05-04 2018-05-17 Ocular Technologies Sarl Topical formulations and uses thereof
DK3373976T3 (da) 2015-11-10 2024-04-02 Sun Pharmaceutical Ind Ltd Topiske formuleringer og anvendelser deraf
WO2017083410A1 (en) 2015-11-12 2017-05-18 Ocular Technologies Sarl Topical formulations and uses thereof
NZ785158A (en) 2016-02-29 2025-03-28 Sun Pharmaceutical Ind Ltd Topical cyclosporine-containing formulations and uses thereof
WO2017152129A2 (en) 2016-03-03 2017-09-08 Ocular Technologies Sarl Treatment of glaucoma and/or retinal diseases and formulations useful therefore

Similar Documents

Publication Publication Date Title
CA2914472C (en) Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
AU2022203135B2 (en) Topical cyclosporine-containing formulations and uses thereof
JP7669326B2 (ja) 局所製剤およびその使用
US20200009137A1 (en) Topical formulations and uses thereof
EP3373924A1 (en) Topical formulations and uses thereof
WO2017152129A2 (en) Treatment of glaucoma and/or retinal diseases and formulations useful therefore
HK40111394A (en) Topical formulations and uses thereof
HK40097708A (en) Topical formulations and uses thereof
HK1260924A1 (en) Topical formulations and uses thereof
HK1260924B (en) Topical formulations and uses thereof